المؤلفون: He, Y, Wu, AC, Harrington, BS, Davies, CM, Wallace, SJ, Adams, MN, Palmer, JS, Roche, DK, Hollier, BG, Westbrook, TF, Hamidi, H, Konecny, GE, Winterhoff, B, Chetty, NP, Crandon, AJ, Oliveira, NB, Shannon, CM, Tinker, AV, Gilks, CB, Coward, JI, Lumley, JW, Perrin, LC, Armes, JE, Hooper, JD

المصدر: Oncogene. 35(4)

مصطلحات موضوعية: Biochemistry and Cell Biology, Biomedical and Clinical Sciences, Biological Sciences, Cancer, Ovarian Cancer, Rare Diseases, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, 2.1 Biological and endogenous factors, Aetiology, Adenocarcinoma, Clear Cell, Animals, Antigens, CD, Antigens, Neoplasm, Carboplatin, Cell Adhesion Molecules, Cell Line, Tumor, Cell Movement, Drug Resistance, Neoplasm, Female, Humans, Kaplan-Meier Estimate, Mice, Inbred NOD, Neoplasm Proteins, Ovarian Neoplasms, Proto-Oncogene Proteins c-akt, Spheroids, Cellular, Xenograft Model Antitumor Assays, Clinical Sciences, Oncology and Carcinogenesis, Oncology & Carcinogenesis, Biochemistry and cell biology, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/74x8x563

المؤلفون: Kulbe, H, Chakravarty, P, Leinster, Da, Charles, Ka, Kwong, J, Thompson, Rg, Coward, Ji, Schioppa, T, Robinson, Sc, Gallagher, Wm, Galletta, L, Australian Ovarian Cancer Study Group, Salako, Ma, Smyth, Jf, Hagemann, T, Brennan, Dj, Bowtell, Dd, Balkwill, Fr.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3662::d52e2184e33fab9723356e7d449b9c92
http://hdl.handle.net/11379/527925

المؤلفون: Khanabdali R; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Mandrekar M; Promega Corporation, Madison, WI 53711, United States., Grygiel R; Promega Corporation, Madison, WI 53711, United States., Vo PA; Promega Corporation, Madison, WI 53711, United States., Palma C; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Nikseresht S; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Barton S; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Shojaee M; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Bhuiyan S; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Asari K; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Belzer S; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Ansari K; INOVIQ Ltd., Notting Hill, VIC 3168, Australia., Coward JI; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; ICON Cancer Care, South Brisbane, QLD 4101, Australia., Perrin L; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Hooper J; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Guanzon D; Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Lai A; Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Salomon C; Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia., Kershner K; Promega Corporation, Madison, WI 53711, United States., Newton C; Promega Corporation, Madison, WI 53711, United States., Horejsh D; Promega Corporation, Madison, WI 53711, United States., Rice G; INOVIQ Ltd., Notting Hill, VIC 3168, Australia.; Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

المصدر: Biology methods & protocols [Biol Methods Protoc] 2024 May 17; Vol. 9 (1), pp. bpae032. Date of Electronic Publication: 2024 May 17 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101693064 Publication Model: eCollection Cited Medium: Internet ISSN: 2396-8923 (Electronic) Linking ISSN: 23968923 NLM ISO Abbreviation: Biol Methods Protoc Subsets: PubMed not MEDLINE

المؤلفون: Samoylovich A; Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia., Jennings B; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia., Shannon C; Medical Oncology, Mater Health Services, South Brisbane, Queensland, Australia., Coward JI; ICON Cancer Care, South Brisbane, Queensland, Australia., Lourie R; Anatomical Pathology, Mater Health Services, South Brisbane, Queensland, Australia., Riordan J; Anaesthesia, Mater Health Services, South Brisbane, Queensland, Australia., Lai NA; Intensive Care Services, Mater Health Services, South Brisbane, Queensland, Australia., van Driel WJ; Department of Gynaecological Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Cabraal N; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia., Jagasia N; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia., Chetty N; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia., Naidu S; Department of General Surgery, Queen Elizabeth II Jubilee Hospital, Brisbane, Queensland, Australia., Perrin LC; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia.; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia., Barry SC; Gynaecological Oncology, Mater Health Services, South Brisbane, Queensland, Australia.; Mater Research Institute - The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.

المصدر: The Australian & New Zealand journal of obstetrics & gynaecology [Aust N Z J Obstet Gynaecol] 2023 Oct; Vol. 63 (5), pp. 702-708. Date of Electronic Publication: 2023 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 0001027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1479-828X (Electronic) Linking ISSN: 00048666 NLM ISO Abbreviation: Aust N Z J Obstet Gynaecol Subsets: MEDLINE

المؤلفون: Coward JI; ICON Cancer Centre, South Brisbane, QLD 4101, Australia.; School of Medicine, University of Queensland, Brisbane, QLD 4072, Australia., Barve MA; Mary Crowley Cancer Research Center, Dallas, TX 75251, USA., Kichenadasse G; Flinders Medical Centre, Adelaide, SA 5042, Australia., Moore KN; Department of Gynecologic Oncology, University of Oklahoma Health Science Center, Stephenson Cancer Center, Oklahoma City, OK 73104, USA., Harnett PR; Crown Princess Mary Cancer Centre, Westmead, NSW 2145, Australia., Berg D; Formerly of Kazia Therapeutics Ltd., Sydney, NSW 2000, Australia., Garner JS; Kazia Therapeutics Ltd., Sydney, NSW 2000, Australia., Dizon DS; Lifespan Cancer Institute, Providence, RI 02913, USA.; The Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.

المصدر: Cancers [Cancers (Basel)] 2021 Jun 26; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Malczewski AB; Icon Cancer Centre, Wesley and South Brisbane, Brisbane, Queensland, Australia agnieszka.malczewski@icon.team.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.; Science and Technology, University of New England, Armidale, New South Wales, Australia., Navarro S; Department of Immunology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; Woolworths Centre for Childhood Nutrition Research, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia., Coward JI; Icon Cancer Centre, Wesley and South Brisbane, Brisbane, Queensland, Australia.; Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia., Ketheesan N; Science and Technology, University of New England, Armidale, New South Wales, Australia.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Immunotherapy/*methods , Metabolome/*physiology , Microbiota/*physiology , Neoplasms/*immunology, Humans

المؤلفون: Khan T; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., He Y; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Kryza T; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Harrington BS; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Gunter JH; Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Translational Research Institute, Brisbane, QLD 4102, Australia., Sullivan MA; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Cuda T; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Rogers R; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Davies CM; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Broomfield A; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Gough M; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Wu AC; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., McGann T; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Weroha SJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA., Haluska P; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.; Bristol-Myers Squibb, Princeton, NJ 08540, USA., Forbes JM; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Armes JE; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Barry SC; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Coward JI; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; ICON Cancer Care, South Brisbane, QLD 4101, Australia., Jagasia N; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Chetty N; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Snell CE; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Lourie R; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Perrin LC; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Brisbane Hospital, Mater Health Services, South Brisbane, QLD 4101, Australia., Hooper JD; Mater Research Institute, The University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.

المصدر: Cancers [Cancers (Basel)] 2020 Apr 03; Vol. 12 (4). Date of Electronic Publication: 2020 Apr 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Xu W; Mater Health Services, Raymond Terrace, Brisbane, QLD 4101, Australia., Rush J; School of Medicine, University of Queensland, St Lucia, QLD 4072, Australia., Rickett K; UQ/Mater McAuley Library, The University of Queensland Library, Brisbane 4101, Australia., Coward JI; Mater Health Services, Raymond Terrace, Brisbane, QLD 4101, Australia; School of Medicine, University of Queensland, St Lucia, QLD 4072, Australia; Princess Alexandra Hospital, Ipswich Road, Woolloongabba, QLD 4102, Australia. Electronic address: Jermaine.Coward@health.qld.gov.au.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2016 Jun; Vol. 102, pp. 26-36. Date of Electronic Publication: 2016 Mar 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma, Mucinous/*drug therapy , Antineoplastic Agents/*therapeutic use , Ovarian Neoplasms/*drug therapy, Adenocarcinoma, Mucinous/epidemiology ; Clinical Trials as Topic ; Female ; Humans ; Molecular Targeted Therapy ; Ovarian Neoplasms/epidemiology ; Ovarian Neoplasms/pathology

المؤلفون: Ho GY; School of Medicine, University of Queensland, QLD 4072, Australia; Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia; Walter & Eliza Hall Institute, 1G Royal Parade, Parkville, VIC 3052, Australia., Woodward N; Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia., Coward JI; School of Medicine, University of Queensland, QLD 4072, Australia; Mater Health Services, Raymond Terrace, South Brisbane, QLD 4101, Australia; Princess Alexandra Hospital, Ipswich Road, Woolloongabba, QLD 4102, Australia. Electronic address: Jermaine.Coward@health.qld.gov.au.

المصدر: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2016 Jun; Vol. 102, pp. 37-46. Date of Electronic Publication: 2016 Mar 24.

نوع المنشور: Comparative Study; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Carboplatin/*therapeutic use , Cisplatin/*therapeutic use , Neoplasms/*drug therapy, Apoptosis ; Female ; Humans

المؤلفون: Harrington BS; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia., He Y; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia., Davies CM; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Wallace SJ; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Adams MN; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Beaven EA; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Roche DK; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia., Kennedy C; Department of Gynaecological Oncology, Westmead Hospital and Centre for Cancer Research, Westmead Millennium Institute, Westmead, NSW 2145, Australia., Chetty NP; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Crandon AJ; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Flatley C; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Oliveira NB; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Shannon CM; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., deFazio A; Department of Gynaecological Oncology, Westmead Hospital and Centre for Cancer Research, Westmead Millennium Institute, Westmead, NSW 2145, Australia., Tinker AV; Cheryl Brown Ovarian Cancer Outcomes Unit, Division of Medical Oncology and Vancouver Centre, British Columbia Cancer Agency, Vancouver, BC, Canada., Gilks CB; Department of Pathology and Laboratory Medicine, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada., Gabrielli B; The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD 4102, Australia., Brennan DJ; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Coward JI; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Armes JE; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Perrin LC; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.; Mater Health Services, South Brisbane, QLD 4101, Australia., Hooper JD; Mater Research Institute, University of Queensland, Translational Research Institute, Woolloongabba, QLD 4102, Australia.; Mater Ovarian Cancer Research Collaborative, Mater Adult Hospital, South Brisbane, QLD 4101, Australia.

المصدر: British journal of cancer [Br J Cancer] 2016 Feb 16; Vol. 114 (4), pp. 417-26. Date of Electronic Publication: 2016 Feb 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD/*metabolism , Cell Adhesion Molecules/*metabolism , Cystadenocarcinoma, Serous/*pathology , Neoplasm Proteins/*metabolism , Ovarian Neoplasms/*pathology, Animals ; Antigens, CD/genetics ; Antigens, Neoplasm ; Biomarkers, Tumor/metabolism ; Cell Adhesion Molecules/genetics ; Cell Line, Tumor ; Cell Movement/physiology ; Cell Proliferation/physiology ; Cystadenocarcinoma, Serous/metabolism ; Disease Models, Animal ; Female ; Heterografts ; Humans ; Mice ; Neoplasm Grading ; Neoplasm Proteins/genetics ; Ovarian Neoplasms/metabolism ; RNA, Small Interfering/administration & dosage ; RNA, Small Interfering/genetics ; Survival Analysis